Skip to main content
Log in

Using molecular dynamics simulation to explore the binding of the three potent anticancer drugs sorafenib, streptozotocin, and sunitinib to functionalized carbon nanotubes

  • Original Paper
  • Published:
Journal of Molecular Modeling Aims and scope Submit manuscript

Abstract

The adsorption of the anticancer drugs sorafenib (SF), streptozotocin (STZ), and sunitinib (STB) on pristine and functionalized carbon nanotubes (FCNTs, functionalized with valine or phenylalanine moieties) was investigated using molecular dynamics simulation. Descriptors such as the van der Waals (vdW) energy, the number of hydrogen bonds, and the radial distribution function were considered. It was found that the type of functional group on the nanotube is a key influence on the vdW interaction energy between a drug molecule and a nanotube. In addition, the positions of the functional groups on a nanotube are a key influence on the adsorption of drug molecules on its surface. Our study indicated that the adsorption of STZ on CNT/FCNTs involves a partial π–π interaction and hydrogen bonding, whereas SF and STB are adsorbed on CNT/FCNTs through π–π stacking and hydrogen bonding. Our results suggest that altering the functionalization of the nanotube surface can affect the drug–nanotube interaction. The results reported here should aid attempts to optimize the design of novel CNT-based drug carriers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

References

  1. Cragg GM, Grothaus PG, Newman DJ (2009) Impact of natural products on developing new anti-cancer agents. Chem Rev 109:3012–3043

  2. Kushwaha S, Rastogi A, Rai A et al (2012) Novel drug delivery system for anticancer drug: a review. Int J Pharm Tech Res 4:542–553

  3. Vashist SK, Zheng D, Pastorin G et al (2011) Delivery of drugs and biomolecules using carbon nanotubes. Carbon 49:4077–4097

  4. Wilhelm S, Carter C, Lynch M et al (2006) Discovery and development of sorafenib: a multikinase inhibitor for treating cancer. Nat Rev Drug Discov 5:835–844

  5. Smalley KS, Xiao M, Villanueva J et al (2009) CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations. Oncogene 28:85–94

  6. Wang XQ, Fan JM, Liu YO et al (2011) Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat. Int J Pharm 419:339–346

  7. Sun L, Liang C, Shirazian S et al (2003) Discovery of 5-[5-fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3 carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase J Med Chem 46:1116–1119

  8. Raymond E, Dahan L, Raoul JL et al (2011) Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 364:501–513

  9. Bagcchi S (2014) Sunitinib still first-line therapy for metastatic renal cancer. Lancet Oncol 15:e420

  10. Moertel CG, Johnson CM, McKusick MA et al (1994) The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 120:302–309

  11. Schlumberger M, Abdelmoumene N, Delisle MJ et al (1995) Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU streptozocin and 5 FU-dacarbazine. Br J Cancer 71:363–365

  12. Broder LE, Carter SK (1973) Pancreatic islet cell carcinoma: II. Results of therapy with streptozotocin in 52 patients. Ann Intern Med 79:108–118

  13. McDevitt MR, Chattopadhyay D, Kappel BJ et al (2007) Tumor targeting with antibody-functionalized, radiolabeled carbon nanotubes. J Nucl Med 48:1180–1189

  14. Liu Z, Chen K, Davis C et al (2008) Drug delivery with carbon nanotubes for in vivo cancer treatment. Cancer Res 68:6652–6660

  15. Wong BS, Yoong SL, Jagusiak A et al (2013) Carbon nanotubes for delivery of small molecule drugs. Adv Drug Deliv Rev 65:1964–2015

  16. Poland CA, Duffin R, Kinloch I et al (2008) Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3:423–428

  17. Liu X, Marangon I, Melinte G et al (2014) Design of covalently functionalized carbon nanotubes filled with metal oxide nanoparticles for imaging, therapy, and magnetic manipulation. ACS Nano 8:11290–11304

  18. Singh R, Torti SV (2013) Carbon nanotubes in hyperthermia therapy. Adv Drug Deliv Rev 65:2045–2060

  19. Liu J, Cui L, Losic D (2013) Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater 9:9243–9257

  20. Kim H, Lee D, Kim J et al (2013) Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide. ACS Nano 7:6735–6746

  21. Kurapati R, Raichur AM (2013) Near-infrared light-responsive graphene oxide composite multilayer capsules: a novel route for remote controlled drug delivery. Chem Commun 49:734–736

  22. Mertz D, Sandre O, Begin-Colin S (2017) Drug releasing nanoplatforms activated by alternating magnetic fields. Biochim Biophys Acta Gen Subj 1861:1617–1641

  23. Liu Z, Tabakman S, Welsher K et al (2009) Carbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug delivery. Nano Res 2:85–120

  24. Colvin VL (2003) The potential environmental impact of engineered nanomaterials. Nat Biotechnol 21:1166–1170

  25. Delogu LG, Venturelli E, Manetti R et al (2012) Ex vivo impact of functionalized carbon nanotubes on human immune cells. Nanomedicine 7:231–243

  26. Bianco A, Kostarelos K, Prato M (2005) Applications of carbon nanotubes in drug delivery. Curr Opin Chem Biol 9:674–679

  27. Liu P (2013) Modification strategies for carbon nanotubes as a drug delivery system. Ind Eng Chem Res 52:13517–13527

  28. Rajarajeswari M, Iyakutti K, Kawazoe Y (2011) Interaction of valine and valine radicals with single-walled carbon nanotube (5, 0). Chem Phys Lett 511:299–303

  29. Chawla S, Pundir CS (2011) An electrochemical biosensor for fructosyl valine for glycosylated hemoglobin detection based on core-shell magnetic bionanoparticles. Biosens Bioelectron 26:3438–3443

  30. Dubey SK, Sharma AK, Narain U, Misra K, Pati U (2008) Design, synthesis and characterization of some bioactive conjugates of curcumin with glycine, glutamic acid, valine and demethylenated piperic acid and study of their antimicrobial and antiproliferative properties. Eur J Med Chem 43:1837–1846

  31. Mahalakshmi R, Jesuraja SX, Jerome Das S (2006) Growth and characterization of L-phenylalanine. Cryst Res Technol 41:780–783

  32. Jeong JS, Sim HJ, Lee YM et al (2009) Determination of phenylalanine in blood by high-performance anionexchange chromatography-pulsed amperometric detection to diagnose phenylketonuria. J Chromatogr A 1216:5709–5714

  33. Kand’ar R, Zakova P (2009) Determination of phenylalanine and tyrosine in plasma and dried blood samples using HPLC with fluorescence detection. J Chromatogr B 877:3926–3929

  34. Deborah M, Jawahar A, Mathavan T et al (2015) Spectroscopic studies on valine-functionalized single-walled carbon nanotubes. Fuller Nanotub Car N 23:649–657

  35. Thakare VS, Das M, al JAK (2010) Carbon nanotubes in cancer theragnosis. Nanomedicine 5:1277–1301

  36. Mallakpour S, Abdolmaleki A, Borandeh S (2014) L-phenylalanine amino acid functionalized multi walled carbon nanotube (MWCNT) as a reinforced filler for improving mechanical and morphological properties of poly(vinyl alcohol)/MWCNT composite. Prog Org Coat 77:1966–1971

  37. Li J, Grennberg H (2006) Microwave-assisted covalent sidewall functionalization of multiwalled carbon nanotubes. Chem Eur J 12:3869–3875

  38. Oyetade OA, Martincigh BS, Skelton AA (2018) Interplay between electrostatic and hydrophobic interactions in the pH-dependent adsorption of ibuprofen onto acid-functionalized multiwalled carbon nanotubes. J Phys Chem C 122:22556–22568

  39. Wolski P, Nieszporek K, Panczyk T (2017) Pegylated and folic acid functionalized carbon nanotubes as pH controlled carriers of doxorubicin. Molecular dynamics analysis of the stability and drug release mechanism. Phys Chem Chem Phys 19:9300–9312

  40. Li Z, Tozer T, Alisaraie L (2016) Molecular dynamics studies for optimization of noncovalent loading of vinblastine on single-walled carbon nanotube. J Phys Chem C 120:4061–4070

  41. Abdolmaleki A, Mallakpour S, Borandeh S (2013) Amino acid-functionalized multi-walled carbon nanotubes for improving compatibility with chiral poly(amide-ester-imide) containing l-phenylalanine and l-tyrosine linkages. Appl Surf Sci 287:117–123

  42. Arsano I, Li S, Wasala M, Tsige M et al (2018) Molecular dynamics of benzoic acid adsorption on carboxylated carbon nanotubes. APS Meeting Abstr F17.013

  43. Ajori S, Ansari R, Darvizeh M (2016) On the vibrational behavior of single-and double-walled carbon nanotubes under the physical adsorption of biomolecules in the aqueous environment: a molecular dynamics study. J Mol Model 22:62

  44. Ansari R, Rouhi S, Ajori S (2018) Molecular dynamics simulations of the polymer/amine functionalized single-walled carbon nanotubes interactions. Appl Surf Sci 455:171–180

  45. Al-Qattan MN, Deb PK, Tekade RK (2017) Molecular dynamics simulation strategies for designing carbon-nanotube-based targeted drug delivery. Drug Discov Today

  46. Ansari R, Ajori S, Malakpour S (2016) Prediction of structural and mechanical properties of atom-decorated porous graphene via density functional calculations. Eur Phys J-Appl Phys 74:10401

  47. Anota EC, Villanueva MS, Shakerzadeh E, Castro M (2018) Adsorption and possible dissociation of glucose by the [BN fullerene-B6] magnetic nanocomposite. In silico studies. Appl Nanosci 8:455–465

  48. Hooshmand S, Es’haghi Z (2018) Hydrophilic modified magnetic multi-walled carbon nanotube for dispersive solid/liquid phase microextraction of sunitinib in human samples. Anal Biochem 542:76–83

  49. Martins-Júnior PA, Alcântara CE, Resende RR, Ferreira AJ (2013) Carbon nanotubes: directions and perspectives in oral regenerative medicine. J Dent Res 92:575–583

  50. Karadas-Bakirhan N, Patris S, Ozkan SA, Can A et al (2016) Determination of the anticancer drug sorafenib in serum by adsorptive stripping differential pulse voltammetry using a chitosan/multiwall carbon nanotube modified glassy carbon electrode. Electroanalysis 28:358–365

  51. Frey JT, Doren DJ (2011) TubeGen3.4 (web interface). J.T. Frey and D.J. Doren, University of Delaware, Newark. http://turin.nss.udel.edu/research/tubegenonline.html

  52. Hess B, Kutzner C, Van Der Spoel D et al (2008) GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4:435–447

  53. Ricci CG, de Andrade AS, Mottin M et al (2010) Molecular dynamics of DNA: comparison of force fields and terminal nucleotide definitions. J Phys Chem B 114:9882–9893

  54. Zoete V, Cuendet MA, Grosdidier A et al (2011) SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 32:2359–2368

  55. Darden T, York D, Pedersen L (1993) Particle mesh Ewald: an N·log (N) method for Ewald sums in large systems. J Chem Phys 98:10089–10092

  56. Berendsen HJ, Postma JV, van Gunsteren WF et al (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684–3690

  57. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33–38

  58. Schmidt MW, Baldridge KK, Boatz JA et al (1993) General atomic and molecular electronic structure system. J Comput Chem 14:1347–1363

  59. Hasanzade Z, Raissi H (2017) Investigation of graphene-based nanomaterial as nanocarrier for adsorption of paclitaxel anticancer drug: a molecular dynamics simulation study. J Mol Model 23:36–43

  60. Hasanzade Z, Raissi H (2017) Solvent/co-solvent effects on the electronic properties and adsorption mechanism of anticancer drug thioguanine on graphene oxide surface as a nanocarrier: density functional theory investigation and a molecular dynamics. Appl Surf Sci 422:1030–1041

  61. Hasanzade Z, Raissi H (2018) Density functional theory calculations and molecular dynamics simulations of the adsorption of ellipticine anticancer drug on graphene oxide surface in aqueous medium as well as under controlled pH conditions. J Mol Liq 255:269–278

  62. Hasanzade Z, Raissi H (2018) Assessment of the chitosan-functionalized graphene oxide as a carrier for loading thioguanine, an antitumor drug and effect of urea on adsorption process: combination of DFT computational and molecular dynamics simulation studies. J Biomol Struct Dyn (accepted)

  63. Hashemzadeh H, Raissi H (2018) Covalent organic framework as smart and high efficient carrier for anticancer drug delivery: a DFT calculations and molecular dynamics simulation study. J Phys D Appl Phys 51:345401

  64. Choudhary V, Gupta A (2011) Polymer/carbon nanotube nanocomposites. In: carbon nanotubes–polymer nanocomposites. InTechOpen, London

  65. Aihara JI (1994) Lack of superaromaticity in carbon nanotubes. J Phys Chem 98:9773–9776

  66. Hashemzadeh H, Raissi H (2017) The functionalization of carbon nanotubes to enhance the efficacy of the anticancer drug paclitaxel: a molecular dynamics simulation study. J Mol Model 23:222

  67. Lu T, Chen F (2012) Multiwfn: a multifunctional wavefunction analyzer J Comput Chem 33:580–592

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Narjes Dehneshin.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 64284 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dehneshin, N., Raissi, H., Hasanzade, Z. et al. Using molecular dynamics simulation to explore the binding of the three potent anticancer drugs sorafenib, streptozotocin, and sunitinib to functionalized carbon nanotubes. J Mol Model 25, 159 (2019). https://doi.org/10.1007/s00894-019-4024-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00894-019-4024-5

Keywords

Navigation